Alpine Immune Sciences Inc (ALPN) USD0.001
Sell:$64.57Buy:$64.69
$0.06 (0.09%)
- This stock can be held in a
Stocks and Shares ISASell:$64.57
Buy:$64.69
Change:$0.06 (0.09%)
$0.06 (0.09%)Prices delayed by at least 15 minutes
Sell:$64.57
Buy:$64.69
Change:$0.06 (0.09%)
$0.06 (0.09%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 26 January 2024 | James Paul RickeyCFO | Sell Option/Award related | 44,000 | $25.00 | $1,100,000.00 | 0 |
| 26 January 2024 | James Paul RickeyCFO | Sell Option/Award related | 73,764 | $22.31 | $1,645,829.74 | 0 |
| 25 January 2024 | James Paul RickeyCFO | Sell Option/Award related | 236 | $22.00 | $5,192.00 | 0 |
| 28 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 26,872 | $19.82 | $532,603.04 | 3,466,613 |
| 28 December 2023 | ALPINE IMMUNOSCIENCES LPManagement Holding | Sell Option/Award related | 48,264 | $19.65 | $948,387.60 | 2,627,157 |
| 28 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 1,195,683 | $18.32 | $21,904,912.56 | 2,270,930 |
| 28 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 3,128 | $19.82 | $61,996.96 | 403,481 |
| 28 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 139,166 | $18.32 | $2,549,521.12 | 264,315 |
| 28 December 2023 | Mitchell H. (Mitch) GoldChairman/CEO | Sell Option/Award related | 1,016 | $20.04 | $20,361.96 | 0 |
| 27 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 162,576 | $19.96 | $3,245,016.96 | 3,493,485 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 28 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 1,195,683 | $18.32 | $21,904,912.56 | 2,270,930 |
| 9 November 2023 | DECHENG CAPITAL GLOBAL HEALTHCARE FUND (MASTER) LPPrivate Equity | Buy Regular purchase transaction | 375,000 | $12.50 | $4,687,500.00 | 1,735,544 |
| 27 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 162,576 | $19.96 | $3,245,016.96 | 3,493,485 |
| 28 December 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 139,166 | $18.32 | $2,549,521.12 | 264,315 |
| 26 January 2024 | James Paul RickeyCFO | Sell Option/Award related | 73,764 | $22.31 | $1,645,829.74 | 0 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.